“…The remaining other 13 studies included patients with aPL positivity and only one of these studies [ 25 ] reported that the presence of aPL was recorded at least twice over 12 weeks apart, whereas all other studies [ 30 , 37 , 33 , 34 , 39 , 40 , 36 , 23 , 24 , 26 , 27 , 29 ] recorded the presence of aPL following a single sample and did not specify that aPL was retested to confirm persistence. A small number of studies included all three criteria aPL (LA; IgG and IgM aCL; and anti-β2GPI) [ 32 , 20–22 , 24 , 25 ], with the combination aCL and LA as the most common included antibodies [ 38 , 34 , 35 , 36 , 28 , 29 ] or aCL as the only included aPL [ 37 , 33 , 31 , 26 , 27 ]. Only five studies indicated their cut-off values for aPL [ 32 , 33 , 37 , 38 , 24 ], with two of these studies using the Sapporo/Sydney laboratory criteria [ 38 , 32 ].…”